Tailored Metal–Phenolic Network with Hypoglycemic Polyphenol for Promoting Diabetic Wound Healing
Source abstract
Abstract
Diabetic foot ulcer is a common and serious complication of diabetes, with a high risk of amputation, recurrence, and mortality. Aiming at the characteristics of diabetic wounds and based on the result of network pharmacology, a tailored ligand cyanidin-3- O -glucoside (C3G) was selected to construct a metal-phenolic network (CM) through the self-assembly reaction with manganese ions. CM integrates the pharmacological advantages of C3G in antidiabetes and the anti-inflammatory activity of metal-phenolic networks by simulating the metal coordination structure of antioxidant enzymes. Reasonably, the wound areas of db/db mice with CM treatment rapidly decreased to 3.06% at day 14, accompanied by the improvement of tissue microenvironment. Mechanism investigation indicated that CM can not only reduce inflammation activation and immunoreaction but also increase gene transcripts in glucose metabolism, response to hypoxia, and angiogenesis. It is believed that this work opens a way for designing disease-specific metal-phenolic networks, and the CM with high biosafety promotes the clinical treatment of diabetic wounds.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Wound Healing and Treatments · Diabetic Foot Ulcer Assessment and Management · Antimicrobial agents and applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Plastic Surgery
The First Affiliated Hospital of Sun Yat-sen University
Department of Dermatology
NMPA Key Laboratory for Research and Evaluation of Drug Metabolism, Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences
Southern Medical University
School of Chemistry and Chemical Engineering
South China University of Technology
Funding
Sun Yat-sen University · National Natural Science Foundation of China
References (66)
Show source-provided references
1. 10.3389/fendo.2022.88165910.3389/fendo.2022.881659 ↗
2. 10.1001/jama.2023.1057810.1001/jama.2023.10578 ↗
3. 10.1002/adfm.20220693610.1002/adfm.202206936 ↗
4. 10.1002/adfm.20160487210.1002/adfm.201604872 ↗
5. 10.1021/acsami.0c1714210.1021/acsami.0c17142 ↗
6. 10.1080/1744666X.2021.191259810.1080/1744666X.2021.1912598 ↗
7. 10.1021/acs.accounts.0c0086410.1021/acs.accounts.0c00864 ↗
8. 10.1016/j.redox.2022.10253010.1016/j.redox.2022.102530 ↗
9. 10.1016/j.biopha.2020.11099110.1016/j.biopha.2020.110991 ↗
10. 10.1016/j.trsl.2018.10.00110.1016/j.trsl.2018.10.001 ↗
11. 10.1002/adhm.20230077910.1002/adhm.202300779 ↗
12. 10.1177/014107681668834610.1177/0141076816688346 ↗
13. 10.1016/j.ejphar.2019.17250010.1016/j.ejphar.2019.172500 ↗
14. 10.1021/acs.jafc.2c0184410.1021/acs.jafc.2c01844 ↗
15. 10.1039/D1FO02385C10.1039/D1FO02385C ↗
16. 10.1021/acs.jafc.0c0319410.1021/acs.jafc.0c03194 ↗
17. 10.3390/ijms2405444110.3390/ijms24054441 ↗
18. 10.3390/nano1303061710.3390/nano13030617 ↗
19. 10.1021/acsnano.3c0194010.1021/acsnano.3c01940 ↗
20. 10.1002/adhm.20230415810.1002/adhm.202304158 ↗
21. 10.1186/s12951-023-02042-710.1186/s12951-023-02042-7 ↗
22. 10.1021/acsami.8b1440910.1021/acsami.8b14409 ↗
23. 10.1021/acsami.3c0276810.1021/acsami.3c02768 ↗
24. 10.1002/adma.20230768010.1002/adma.202307680 ↗
25. 10.1002/adhm.20220306310.1002/adhm.202203063 ↗
26. 10.1186/s12951-024-02472-x10.1186/s12951-024-02472-x ↗
27. 10.1186/s12951-024-02985-510.1186/s12951-024-02985-5 ↗
28. 10.1021/acsami.3c1962110.1021/acsami.3c19621 ↗
29. 10.1002/adma.20210578310.1002/adma.202105783 ↗
30. 10.1186/s12951-023-01771-z10.1186/s12951-023-01771-z ↗
31. 10.1002/smll.20220782510.1002/smll.202207825 ↗
32. 10.1021/jacs.1c0975310.1021/jacs.1c09753 ↗
33. 10.1002/smll.20170271410.1002/smll.201702714 ↗
34. 10.1002/smll.20210078910.1002/smll.202100789 ↗
35. 10.1186/s12951-022-01416-710.1186/s12951-022-01416-7 ↗
36. 10.1021/acsami.7b1932210.1021/acsami.7b19322 ↗
37. 10.1002/adhm.20230360410.1002/adhm.202303604 ↗
38. 10.1002/adhm.20210079310.1002/adhm.202100793 ↗
39. 10.1021/acsami.4c0709110.1021/acsami.4c07091 ↗
40. 10.1016/S0968-0896(03)00070-110.1016/S0968-0896(03)00070-1 ↗
41. 10.1021/acs.analchem.2c0376510.1021/acs.analchem.2c03765 ↗
42. 10.2298/HEMIND140711072R10.2298/HEMIND140711072R ↗
43. 10.1016/S0140-6736(05)67700-810.1016/S0140-6736(05)67700-8 ↗
44. 10.1016/j.biomaterials.2020.12028610.1016/j.biomaterials.2020.120286 ↗
45. 10.1016/j.redox.2023.10292710.1016/j.redox.2023.102927 ↗
46. 10.1016/j.biopha.2021.11130310.1016/j.biopha.2021.111303 ↗
47. 10.1016/j.lfs.2021.11969310.1016/j.lfs.2021.119693 ↗
48. 10.1038/s41467-024-54894-810.1038/s41467-024-54894-8 ↗
49. 10.1016/j.jbc.2021.10153010.1016/j.jbc.2021.101530 ↗
50. 10.7150/ijbs.8846110.7150/ijbs.88461 ↗
51. 10.1002/adfm.20211102210.1002/adfm.202111022 ↗
52. 10.1161/ATVBAHA.118.31070310.1161/ATVBAHA.118.310703 ↗
53. 10.3389/fphys.2018.0041910.3389/fphys.2018.00419 ↗
54. 10.1186/s13287-020-02014-w10.1186/s13287-020-02014-w ↗
55. 10.1021/acsami.3c0473310.1021/acsami.3c04733 ↗
56. 10.1016/j.ijbiomac.2022.06.19610.1016/j.ijbiomac.2022.06.196 ↗
57. 10.1016/j.actbio.2022.11.02310.1016/j.actbio.2022.11.023 ↗
58. 10.1002/adhm.20230007410.1002/adhm.202300074 ↗
59. 10.1002/adhm.20160065810.1002/adhm.201600658 ↗
60. 10.1016/j.actbio.2022.10.03810.1016/j.actbio.2022.10.038 ↗
61. 10.1016/j.msec.2020.11168910.1016/j.msec.2020.111689 ↗
62. 10.1016/j.ijbiomac.2016.05.03810.1016/j.ijbiomac.2016.05.038 ↗
63. 10.1002/ptr.809910.1002/ptr.8099 ↗
64. 10.1016/j.ijpharm.2023.12357610.1016/j.ijpharm.2023.123576 ↗
65. 10.1002/adfm.20210433710.1002/adfm.202104337 ↗
66. 10.1016/j.cytogfr.2019.03.00110.1016/j.cytogfr.2019.03.001 ↗